Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study

van^Oijen, M.; Cheung, E. Y. L.; Geluk, C. E. M.; Hofman, A.; Koudstaal, P. J.; Breteler, M. M. B.; de Maat, M. P.
July 2008
Journal of Neurology, Neurosurgery & Psychiatry;Jul2008, Vol. 79 Issue 7, p799
Academic Journal
Objective: Fibrinogen levels and fibrinogen clot structure have been implicated in the pathogenesis of vascular disease. We examined fibrinogen levels and variation in fibrinogen genes (fibrinogen γ (FGG), α (FGA) and β (FGB)), which have been associated with fibrin clot structure and fibrinogen levels, in relation to cerebral small vessel disease (SVD). Methods and results: This study was performed as part of the Rotterdam Scan Study, a population based study in 1077 elderly patients undergoing cerebral MRI. Plasma fibrinogen levels and haplotypes were determined. We examined the association between fibrinogen levels and haplotype with silent brain infarcts and white matter lesions using logistic regression models. We constructed seven haplotypes )frequency >0.01) that describe the total common variation in the FOG and FGA genes. Haplotype 2 (GATAGTG) was associated with the presence of silent brain infarcts compared with the most frequent haplotype (GGTGGTA) (OR 1.41, 95% Cl 1.03 to 1.94). Haplotype 3 (GGCGATA) was associated with periventricular white matter lesions in the highest tertile of the distribution (OR 1.40, 95% Cl 1.01 to 1.92). No association was found between plasma fibrinogen levels and SVD. Conclusions: Our study provides evidence for an association of common variation in the FOG and FGA genes with cerebral SVD. It is possible that the structure of the fibrin clot rather than plasma fibrinogen levels plays a role in the pathogenesis of cerebral SVD.


Related Articles

  • Structural Basis for Variable Lytic Susceptibility of Fibrin Bridging Structure with Function in Fibrinolysis. Kolev, K. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2008, Vol. 6 Issue 3, p159 

    The article discusses various reports published within the issue, including one by Russell F. Doolittle on the ultrastructural changes accompanying the conversion of fibrinogen to fibrin and another by M. Hoffman on the alterations of fibrinogen structure in human disease.

  • Fragment E Derived from both Fibrin and Fibrinogen Stimulates Interleukin-6 Production in Rat Peritoneal Macrophages. Mi-Eun Lee; Ki Jong Rhee; Sang-Uk Nham // Molecules & Cells (Springer Science & Business Media B.V.);1999, Vol. 9 Issue 1, p7 

    Provides information on a study which presented an additional biological role of fibrin and fibrinogen. Materials and methods; Results and discussion.

  • A Locus on Chromosome 13 Influences Levels of TAFI Antigen in Healthy Mexican Americans. Warren, D. M.; Cole, S. A.; Dyer, T. D.; Soria, J. M.; Souto, J. C.; Fontcuberta, J.; Blangero, J.; Maccluer, J. W.; Almasy, L. // Human Biology;Jun2006, Vol. 78 Issue 3, p329 

    When activated, thrombin activatable fibrinolysis inhibitor (TAFI) inhibits fibrinolysis by modifying fibrin, depressing its plasminogen binding potential. Polymorphisms in the TAFI structural gene (CPB2) have been associated with variation in TAFI levels, but the potential occurrence of...

  • FDP.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p853 

    An encyclopedia entry for FDP which stands for fibrin degradation products is presented.

  • fibrinopenia.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p866 

    A definition of the medical term "fibrinopenia," which refers to fibrin and fibrinogen deficiency in the blood, is presented.

  • Fibrinogen and Fibrin (Book). Didisheim, Paul // Annals of Internal Medicine;Jan65, Vol. 62 Issue 1, p183 

    Reviews the book 'Fibrinogen and Fibrin: Turnover of Clotting Factors. Transactions of the Conference held under the Auspices of the International Committee on Blood Clotting Factors, Gleneagles, Scotland, July 1963,' edited by R.B. Hunter, F. Koller and E. Beck.

  • A Fibrin Glue Composition as Carrier for Nucleic Acid Vectors. Ulrike Schillinger; Christian Hacker; Martin Kullmer; Christian Koch; Michael Gerg; Stephan Vogt; Peter Ueblacker; Thomas Tischer; Daniel Hensler; Jonas Wilisch; Joachim Aigner; Axel Stemberger; Christian Plank // Pharmaceutical Research;Dec2008, Vol. 25 Issue 12, p2946 

    Abstract Purpose  Gene delivery from biomaterials has become an important tool in tissue engineering. The purpose of this study was to generate a gene vector-doted fibrin glue as a versatile injectable implant to be used in gene therapy supported tissue regeneration. ...

  • Novel Oral Anticoagulants. Halperin, Jonathan L. // MD Conference Express;May2010, p30 

    The article discusses the 2 most immediate targets for oral anticoagulants, such as the Factor IIa (thrombin) and Factor Xa. It states that Factor IIa (thrombin), which is the final step in the cascade before the fibrin formation, holds the advantage of likely interfering with interaction...

  • Fibrinogen and Fibrin are Anti-Adhesive for Keratinocytes: A Mechanism for Fibrin Eschar Slough During Wound Repair. Kubo, Miyoko; Van De Water, Livingston; Plantefaber, Lisa C.; Mosesson, Michael W.; Simon, Marcia; Tonnesen, Marcia G.; Taichman, Lorne; Clark, Richard A.F. // Journal of Investigative Dermatology;Dec2001, Vol. 117 Issue 6, p1369 

    During cutaneous wound repair the epidermis avoids the fibrin-rich clot; rather it migrates down the collagen-rich dermal wound margin and over fibronectin-rich granulation tissue. The mechanism(s) underlying keratinocyte movement in this precise pathway has not been previously addressed. Here...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics